All episodes
AUA2018 Take Home Messages Female Urology Incontinence - QIPS
AUA2018 Take Home Messages Prostate Cancer - BPH LUTS
AUA2018 Take Home Messages Penile Urethral Cancer - Outcomes
AUA2018 Take Home Messages Minimally Invasive Surgery - Imaging
AUA2018 Take Home Messages Pediatrics plus Highlights From SPU and Journal of Urology
Use of Novel Hormonal Agents and Systemic Therapy in Advanced Prostate Cancer Highlights (2018)
Immuno-Oncology: A Focus on Prostate Cancer
AUA2018 Residents Forum - The Evolving Practice Of Urology
AUA2018 Residents Forum - Wellness Burnout And Sustaining Your Career
Immuno-Oncology: A Focus on Kidney Cancer
Sequencing of Chemotherapy and Immunotherapy in Advanced Prostate Cancer Present and Future (2018)
Incorporating New IO Therapies - How to Properly Administer IO Therapies in an Infusion Suite
Immuno-Oncology: A Focus on Bladder Cancer
AUA2018 Residents Forum: Public Policy and Advocacy in Urology: A Primer for Residents
Incorporating New IO Therapies - Managing Patient Side Effects
Immuno - Oncoloy: A New Class Of Drugs
Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer
Incorporating New IO Therapies - Biomarkers
Castration-Resistant Prostate Cancer (CRPC) Guideline Amendment
AUA2018 Take Home Messages - Infertility Andrology And Sexual Dysfunction
AUA2018 Take Home Messages - Endourology Stones - Infection Inflammation
Emerging Treatment Options For Non - Metastatic CRPC Sept 2018
Match Or Mismatch Presented by National Medical Student Education Committee
Emerging Treatment of M0 CRPC: Update on the AUA/SUO Guidelines
AUA2018 Take Home Messages Basic Sciences - Trauma
The Changing Landscape of Advanced Prostate Cancer Management: What You Need to Know
AUA2018 043IC - Novel Agents and Concepts in the Management of Hormone Naïve
AUA2018 078IC - Management of Prostate Cancer: A Case Based Approach
AUA2018 019IC: Immunotherapy for the Urologist: Basic Principles, Adverse Effects & Drug Delivery
AUA2018 063IC - Prostate Cancer Update
AUA2018 005IC - Chemotherapy and Immunotherapy Options for Genitourinary :A Primer for the APP
AUA2018 058IC - Management of Common Dilemmas in Prostate Cancer Diagnosis, Staging and Treatment
Highlights in Renal Cell Carcinoma: Coordination of Care & the Patient's Journey (2018)
AUA2018 031IC: Contemporary Pharmacotherapy for OAB
Focal Therapy Interview with John W. Davis, MD, FACS
Highlights in Renal Cell Carcinoma: The Evolving Landscape of Adjuvant Therapy (2018)
Highlights in Renal Cell Carcinoma: The Roles of the Urologist and Medical Oncologist (2018)
AUA2018 074IC - AUA CRPC Guidelines
AUA2018 Contemporary Pharmacotherapy for OAB
Minimally Invasive Treatment Of BPH
Update on Medical and Surgical Management of Advanced Testis Cancer
AUA2017 Court is in Session: Sepsis after Mini PNCL
CRPC Sequencing Agents
AUA CRPC Guidlines Overview
AUA2017 Court is in Session: Myocardial Infarction on Androgren Replacement Therapy
AUA2017: Court is in Session: Colostomy after Robotic Prostatectomy
AUA2017 Take Home Messages: Bladder Cancer - Transplantation - Female Urology
AUA2017 Take Home Messages: BPH/LUTS - Minimally Invasive Surgery - Quality
AUA2017 Take Home Messages: Pediatrics | Penile/Urethral Cancer | Kidney Cancer
AUA2017 Take Home Messages: Infertility/Andrology | Outcomes | Sexual Dysfunction
AUA2017 Take Home Messages: Prostate Cancer, Basic Sciences, and Trauma/Reconstruction
Bladder Cancer Immunotherapy Series: Complex Patient Cases
PSA Screening changes and USPSTF Recommendations
Bladder Cancer Immunotherapy Series: AUA Guideline
Low Testosterone
SUFU Clinical Care Pathway
Bladder Cancer Immunotherapy Series: Immunotherapy: From Research to Practice #1
Core Curriculum Video Abstract Request
Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer
Transgender; What Every Urologist Should Know
AUA Choosing Wisely
Shared Decision Making
CRPC 2016
Endourology
Female Sexual Dysfunction